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 In the emergency department (ED) many barriers exist to pain 
management, including its subjective nature, regulatory issues, 
knowledge deficits, and fear concerning therapy. 
 NSAIDs and acetaminophen often cannot provide enough relief. 
Opioids have significant adverse effect profiles and are hindered by 
side effects, dependency, and tolerance. 
o The Joint Commission highlighted issues with opioid prescribing 
and related adverse events in a 2012 Sentinel Event Alert.  
o The American College of Emergency Physicians has instituted 
efforts to reduce unnecessary and improper opioid prescribing. 
 A non-competitive NMDA receptor antagonist with properties that 
allow for little respiratory depression, ketamine has historically been 
used for sedation and anesthesia in settings with limited resources. 
 Ketamine’s unique safety profile in the anesthetic setting and variety 
of dosage forms indicate its potential role in pain management.  
To assess the safety and efficacy of using low-dose ketamine (LDK) for 
pain management. Data will be used to evaluate the use of ketamine in 
treating mild-to-severe pain in a high-volume community hospital 
emergency department, and to recommend a dosing guideline for its use 
in the ED. 
Study Design: An observational study utilizing retrospective medical 
chart reviews of a sample of patients who received low-dose ketamine 
during a visit to the Emergency Department at Homestead Hospital. 
Sample Size: 24 subjects. 
Inclusion Criteria: Admission to the Homestead Hospital ED for 
treatment of acute or chronic mild, moderate, or severe pain with 
ketamine between June 2014 and June 2015.  
Exclusion Criteria: Administration of ≥ 1 mg/kg of ketamine. 
Instruments: The Wong-Baker FACES Pain Rating Scale for children, a  
1-10 Visual Analogue Scale for adults, and provider documentation. 
Procedures: A retroactive computerized report was generated to identify 
all patients who received ketamine in the ED between June 2014 and 
June 2015. Any patients who did not fit the study criteria were excluded. 
Subjects’ profiles were then reviewed by a pre-specified investigator to 
determine how LDK was used to treat patients’ pain symptoms. Safety 
and effectiveness were assessed by the incidence of adverse events and 
changes in subjectively reported pain-rating scores, respectfully.  
Statistical Analysis: Descriptive statistics were generated using Microsoft 
Office Excel 2007 to assess how LDK was used in the ED, for what 
indications, the safety profile of the dosage range being used, and the 
effectiveness of LDK in reducing pain. 
 Of 113 subjects with orders for ketamine, 24 met inclusion criteria.  
o 34 ketamine orders were discontinued prior to administration. 
 1 patient refused treatment with LDK. 
o 55 subjects received ≥ 1 mg/kg of ketamine. 
 A total average dose of 0.375 mg/kg was administered for eight 
distinct indications, with the highest doses being used for laceration 
repair and the lowest for a hairline fracture.  
 Ketamine monotherapy reduced an average baseline pain rating of 
Severe to Mild upon discharge, in a manner similar to 
coadministration with analgesics and sedative agents. 
 Common coadministered medications included opioid and non-
opioid analgesics, ondansetron, and propofol. 
 Two adverse drug events were reported for separate subjects. 
o Twenty minutes after ketamine administration, a patient 
vomited yellow bile. Per patient request, ketamine drip was held. 
Patient was nauseous upon presentation.  
o Three minutes after ketamine administration, oxygen saturation 
decreased 5% and then returned to baseline after five minutes. 
 Low-dose ketamine was safely administered to treat a variety of 
different indications in opioid-naïve and opioid-tolerant patients. 
 Ketamine was effective in doses < 1 mg/kg for providing emergency 
analgesia in the ED, both as monotherapy and adjunctively. 
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Patient Demographics (n=24) 
Age (yr), average 34.4 Existing Precautions (%) 25 
Weight (kg), average 70.5 Coronary Artery Disease (%) 8.3 
Sex Heart Failure (%) 8.3 
Female (%) 54 Hypertension (%)  20.8 
Male (%) 46 Baseline Vital Signs 
Baseline Pain Score Heart Rate (bpm), average 104 
Mild (%) 4.3 Systolic Blood Pressure (mmHg), average 129 
Moderate (%) 8.7 Diastolic Blood Pressure (mmHg), average 79 
Severe (%) 87 Oxygen Saturation (%), average 99 
Post-LDK Pain Score History of Chronic Pain (%) 37.5 
None (%) 42.9 History of Opioid Use (%)  37.5 
Mild (%) 28.6 Opioid use within the past 24 hours (%) 37.5 
Moderate (%) 23.8 
Severe (%) 4.8 
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Avg. Baseline Pain 7.3 8.5 7.6 
Avg. Pain at Discharge 1.8 2.5 2.3 
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Change in Pain from Baseline 
IV Push 81% 
(n=22) 
Continuous 
Infusion 15% 
(n=4) 
Intranasal 4% 
(n=1) 
Administration Routes 
No ADE 92% 
(n=22) 
Vomiting 4% 
(n=1) 
Decreased SpO2  
4% (n=1) 
Incidence of Adverse Drug Events 
Coadministered Medications 
None 18% n=8 Ondansetron 16% n=7 
Atropine 2% n=1 Opiate analgesics 21% n=9 
Benzodiazepines 5% n=2 Opiates + APAP 7% n=3 
Diphenhydramine 5% n=2 Orphenadrine 2% n=1 
NSAIDs 12% n=5 Propofol 12% n=5 
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